Defining 'full-length' recombinant factor VIII: a comparative structural analysis. - Wikidata - wikimedia - TriplyDB

Defining 'full-length' recombinant factor VIII: a comparative structural analysis.

Defining 'full-length' recombinant factor VIII: a comparative structural analysis.

http://www.wikidata.org/entity/Q30359132

about

Expression and characterization of a codon-optimized blood coagulation factor VIII.Purification and characterization of a new recombinant factor VIII (N8).Efficacy, Safety, and Pharmacokinetics of Beroctocog Alfa in Patients Previously Treated for Hemophilia A.Functional factor VIII made with von Willebrand factor at high levels in transgenic milk The use of PEGylated liposomes in the development of drug delivery applications for the treatment of hemophilia.Blood Clotting Factor VIII: From Evolution to Therapy.Turoctocog alfa (NovoEight®)--from design to clinical proof of concept.Turoctocog alfa: an evidence-based review of its potential in the treatment of hemophilia A BAY 81-8973, a full-length recombinant factor VIII: manufacturing processes and product characteristics.In vitro characterization of recombinant factor VIII concentrates reveals significant differences in protein content, activity and thrombin activation profile.Enhanced Proteolytic Processing of Recombinant Human Coagulation Factor VIII B-Domain Variants by Recombinant Furins.Biochemical and functional characterization of a recombinant monomeric factor VIII-Fc fusion protein Binding of recombinant human coagulation factor VIII to lipid nanotubes.Structural analysis of the recombinant therapeutic product rFVIII and its PEGylated variants using 2-D DIGE.Identification of Aggregates in Therapeutic Formulations of Recombinant Full-Length Factor VIII Products by Sedimentation Velocity Analytical Ultracentrifugation.Mixture of three amino acids as stabilizers replacing albumin in lyophilization of new third generation recombinant factor VIII GreenGene F.

P2860

Q30397756-14086A0F-690E-462D-8783-AE697674CE93 Q30881997-00AC413B-0724-415D-AA72-6AF6D2C43CA4 Q35778288-E3779D38-4E92-42DE-B137-96E445893543 Q36239576-7EEDD4EC-CC9B-4992-BC23-70CE655F95BE Q37790614-AB514B60-EC00-4A6E-A44F-719FEBCCF532 Q38118763-4F4FE78C-4B41-4022-B259-145F18BAE25D Q38209486-2E2EC918-C5D6-4C2A-A28C-37A6FF31F61C Q38408739-0FDE007F-9ED8-4573-A3BC-F9362C86C603 Q38725317-B8DF2623-667E-4749-A938-C6F1DC52F91C Q39223784-1BCBD34A-9823-4B39-BA2B-F252423160C4 Q39811881-A808E696-85FB-4FAD-A128-4D96CE58A2CD Q41611929-15D68AFF-0665-48DE-858B-D6D96124989A Q41622973-BF38616B-CA30-4291-980C-A8BF04C1EDB8 Q45869545-FAFAEE39-34D8-4422-BAEA-A2E0E55F37C6 Q45875342-3F7450BE-5AA3-49F3-8EEE-29CC7DFADC92 Q50490090-F095DAE2-2CC7-4B81-AB37-502DA420E95E

P2860

Defining 'full-length' recombinant factor VIII: a comparative structural analysis.

http://www.wikidata.org/entity/Q30359132

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Defining 'full-length' recombinant factor VIII: a comparative structural analysis.

@ast

Defining 'full-length' recombinant factor VIII: a comparative structural analysis.

@en

type

label

Defining 'full-length' recombinant factor VIII: a comparative structural analysis.

@ast

Defining 'full-length' recombinant factor VIII: a comparative structural analysis.

@en

prefLabel

Defining 'full-length' recombinant factor VIII: a comparative structural analysis.

@ast

Defining 'full-length' recombinant factor VIII: a comparative structural analysis.

@en

P1433

Q30359132-5220575A-1A09-48B1-A83E-ED1AF900012C

P1476

Q30359132-53436DB7-9796-4358-B775-F8D0F8428C02

P2093

Q30359132-76A3BF6A-3351-4816-819E-95F4BE67C49B

Q30359132-8E29106B-3CB8-408B-9553-B17E1DCB4E71

Q30359132-911AD089-B26B-4A0D-90A1-4A8FDE6F7C95

Q30359132-9FCF568A-E89A-4737-8FF4-60DEBB47D8C3

Q30359132-CFFEFCA2-0BFD-4B6B-8E98-0BF7D36871A6

Q30359132-E212109C-3D01-4A38-83DC-A731380A3AE1

P2860

Q30359132-11A1DE7E-42C5-4B7B-B1FA-706A668962E4

Q30359132-29BF78FC-222A-4150-A760-83EC9594FC3A

Q30359132-2D785294-49B0-4E05-8890-45320060C1D2

Q30359132-302ADAB0-6937-439F-BA9D-933CC0AE05C0

Q30359132-4691C6DA-79B0-4CF4-9EC2-1BAEF065FA0A

Q30359132-6E82DCC0-2A2D-466E-BB8C-51259DA0A3F4

Q30359132-7523AE5C-5CCC-4876-98A9-AC70075D0104

Q30359132-78200CFE-6B0B-4622-B606-B5A524CE4646

Q30359132-AE9676C9-6C02-4ED2-B63B-CC8852A0297A

Q30359132-C6A65322-9794-4397-87D6-05144500E392

P304

Q30359132-1A02146F-18A5-4FE3-9BE0-BC45FD9BCC94

P31

Q30359132-398E96C4-3581-4918-9F56-C0AC8D54F5E1

P356

Q30359132-05978582-AB36-4DE8-8F5C-183D9611486B

P433

Q30359132-C9CAF839-821A-4623-93FD-FDCB25F5FDFF

P478

Q30359132-BAF4B282-D21E-4380-BDFD-6AC41D5D2355

P577

Q30359132-2EC896AA-3FDE-4681-87DF-FC69D0316DC7

P698

Q30359132-721E00B1-90DB-46C3-AF6A-7801F2FFE2C4

P356

J.1365-2516.2006.01388.X

P1433

P1476

Defining 'full-length' recombinant factor VIII: a comparative structural analysis.

@en

P2093

Jankowski MA

http://www.w3.org/2001/XMLSchema#string

Marzilli LA

http://www.w3.org/2001/XMLSchema#string

Patel H

http://www.w3.org/2001/XMLSchema#string

Rouse JC

http://www.w3.org/2001/XMLSchema#string

Sharpe PJ

http://www.w3.org/2001/XMLSchema#string

Weston SB

http://www.w3.org/2001/XMLSchema#string

P2860

The relationship of N-linked glycosylation and heavy chain-binding protein association with the secretion of glycoproteins

In search of the eighth factor: a personal reminiscence

Molecular cloning of a cDNA encoding human antihaemophilic factor

Structure of human factor VIII

Isolation and characterization of human factor VIII: molecular forms in commercial factor VIII concentrate, cryoprecipitate, and plasma.

Characterization of the human factor VIII procoagulant protein with a heterologous precipitating antibody.

Structural characterization of site-specific N-glycosylation of recombinant human factor VIII by reversed-phase high-performance liquid chromatography-electrospray ionization mass spectrometry.

A large region (approximately equal to 95 kDa) of human factor VIII is dispensable for in vitro procoagulant activity.

Identification and functional requirement of Cu(I) and its ligands within coagulation factor VIII.

Can we improve on nature? "Super molecules" of factor VIII.

P304

30-37

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2516.2006.01388.X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17212722

http://www.w3.org/2001/XMLSchema#string